MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
3.620
-0.110 (-2.95%)
Aug 14, 2025, 2:06 PM - Market open
MannKind Employees
As of December 31, 2024, MannKind had 407 total employees, including 403 full-time and 4 part-time employees. The number of employees decreased by 7 or -1.69% compared to the previous year.
Employees
407
Change (1Y)
-7
Growth (1Y)
-1.69%
Revenue / Employee
$741,366
Profits / Employee
$80,585
Market Cap
1.11B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MNKD News
- 7 days ago - MannKind Corporation (MNKD) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 7 days ago - MannKind Corporation: A Post-Q2 Assessment - Seeking Alpha
- 8 days ago - MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement - GlobeNewsWire
- 8 days ago - MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update - GlobeNewsWire
- 14 days ago - MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025 - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks That May Rocket Higher This Quarter - Benzinga
- 2 months ago - MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23 - GlobeNewsWire
- 2 months ago - INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29 - GlobeNewsWire